NCT04698798View on ClinicalTrials.gov

Skeletal Muscle Wasting in SARS-CoV-2

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 2, 2021

Primary Completion Date

April 3, 2021

Study Completion Date

April 3, 2021

Conditions
CachexiaMuscle LossMuscle WastingMuscle AtrophyCritical Illness
Interventions
PROCEDURE

Muscle Biopsy

Patients will be treated for SARS-CoV-2 symptoms on the intensive care unit. During this treatment two muscle biopsies will be obtained with an interval of seven days between them.

Trial Locations (1)

3500

Jessa Ziekenhuis, Hasselt

All Listed Sponsors
collaborator

Jessa Hospital

OTHER

lead

Hasselt University

OTHER

NCT04698798 - Skeletal Muscle Wasting in SARS-CoV-2 | Biotech Hunter | Biotech Hunter